# CHOP/Rituximab Followed by Maintenance PEG Intron in Treatment of Indolent/Follicular Non-Hodgkin's Lymphoma

> **NCT00574730** · NA · COMPLETED · sponsor: **University of Nebraska** · enrollment: 27 (actual)

## Conditions studied

- Non-Hodgkins Lymphoma

## Interventions

- **DRUG:** CHOP/Rituximab
- **DRUG:** PEG INTRON

## Key facts

- **NCT ID:** NCT00574730
- **Lead sponsor:** University of Nebraska
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-05-23
- **Primary completion:** 2005-08-01
- **Final completion:** 2012-06-07
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2023-09-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00574730

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00574730, "CHOP/Rituximab Followed by Maintenance PEG Intron in Treatment of Indolent/Follicular Non-Hodgkin's Lymphoma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00574730. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*